Scientific work

Doç. Dr. Semiha Urvay

33 publications. The source of the information is stated next to each publication.

Back to profile
  1. Evaluation of inflammatory parameters and ferritin as prognostic factors in non-small cell lung cancer patients receiving nivolumab immunotherapy

    Biomarkers, 2026

    DOI 10.1080/1354750x.2026.2621291 PMID 41579336 1 citation (Europe PMC) Source: OpenAlex

  2. Bone Metastasis Distribution Matters: Prognostic Effect of the Axial‐to‐Peripheral Ratio in Metastatic Hormone‐Sensitive Prostate Cancer

    The Prostate, 2026

    DOI 10.1002/pros.70176 PMID 41950364 Source: OpenAlex

  3. Does the Duration of FLOT Infusion Change the Outcome of Perioperative Treatment for Gastric Cancer? Comparing 24- and 48-h Infusions

    Medicina, 2026

    DOI 10.3390/medicina62050987 PMID 42195240 Open-access full textSource: OpenAlex

  4. Palliative Care Awareness Among Caregivers of Cancer Patients in Turkey: A Cross-Sectional Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33080458 PMID 42645362 Open-access full textSource: OpenAlex

  5. Assessing Early Treatment Response in mCSPC using KELIM PSA Score: Implications for Survival

    Urologia Internationalis, 2026

    DOI 10.1159/uin/aewag017 PMID 42671968 Source: OpenAlex

  6. Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-96157-6 PMID 40188172 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks?

    European Journal of Clinical Pharmacology, 2025

    DOI 10.1007/s00228-025-03810-0 PMID 39971806 1 citation (Europe PMC) Source: OpenAlex

  8. Prognostic Effect of KELIM Score of Prostate‐Specific Antigen in Hormone‐Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways

    The Prostate, 2025

    DOI 10.1002/pros.70098 PMID 41277135 Source: OpenAlex

  9. HEREDITARY COLORECTAL CANCER SYNDROMES

    Turkiye Klinikleri eBooks, 2025

    DOI 10.5336/978-625-395-770-4_p17 Source: OpenAlex

  10. A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy

    Medicine, 2024

    DOI 10.1097/md.0000000000037972 PMID 38787994 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  11. 1523P Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer

    Annals of Oncology, 2024

    DOI 10.1016/j.annonc.2024.08.1586 Source: OpenAlex

  12. Evaluating the effect of tumor size and sidedness on prognosis in stage 2 colon cancer: a retrospective population study.

    PubMed, 2022

    DOI 10.26355/eurrev_202202_28126 PMID 35253189 1 citation (Europe PMC) Source: OpenAlex

  13. Onkolojide Moleküler Hedefli Tedaviler

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1478 Open-access full textSource: OpenAlex

  14. Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience

    Cancer Investigation, 2021

    DOI 10.1080/07357907.2021.1933011 PMID 34014777 10 citations (Europe PMC) Open-access full textSource: OpenAlex

  15. Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00594-1 PMID 33538958 4 citations (Europe PMC) Source: OpenAlex

  16. Prognostic role of pre-operative serum ferritin level in stage 2 colon cancer.

    PubMed, 2021

    DOI 10.26355/eurrev_202111_27091 PMID 34787851 12 citations (Europe PMC) Source: OpenAlex

  17. Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer

    Tumori Journal, 2020

    DOI 10.1177/0300891620969823 PMID 33167790 4 citations (Europe PMC) Source: OpenAlex

  18. Chemotherapy at the End of Life

    Journal of Palliative Care, 2020

    DOI 10.1177/0825859720946505 PMID 32762320 11 citations (Europe PMC) Source: OpenAlex

  19. The role of primary tumor resection in patients with stage IV colorectal cancer with unresectable metastases.

    PubMed, 2020

    PMID 32521889 7 citations (Europe PMC) Source: OpenAlex

  20. P1.01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

    Journal of Thoracic Oncology, 2018

    DOI 10.1016/j.jtho.2018.08.601 Open-access full textSource: OpenAlex

  21. Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experince from Turkey

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  22. Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

    Bursa Uludag University - AVESIS, 2018

    Source: OpenAlex

  23. CRIZOTINIB EFFICACY IN ALK-POSITIVE ADVANCEDSTAGE NON-SMALL CELL LUNG CANCER PATIENTS: A REAL-WORLD EXPERIENCE FROM TURKEY

    Kocaeli Üniversitesi - AVESİS, 2018

    Source: OpenAlex

  24. Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

    Journal of Cancer Education, 2018

    DOI 10.1007/s13187-018-1441-6 PMID 30446981 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  25. Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less

    Anti-Cancer Drugs, 2016

    DOI 10.1097/cad.0000000000000445 PMID 27768606 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  26. Mide Kanserinde Tanı Anındaki Evre ile Patolojik Alt Tip ve Lokalizasyonun İlişkisi

    2015

    Source: OpenAlex

  27. Meme Kanseri Hastalarında Tümör Belirteçleriyle Evre ve Prognostik Faktörler Arasındaki İlişki

    Trakya University's Institutional Open Access System (Trakya University), 2014

    Open-access full textSource: OpenAlex

  28. Gliomlara yaklaşım ve yeni tedaviler

    2013

    Source: OpenAlex

  29. Hastalarımızda tromboz sıklığı ve literatürün gözden geçirilmesi

    2012

    Source: OpenAlex

  30. Mide kanserinde helicobacter pylori infeksiyonu ile sağkalım arasındaki ilişki

    2011

    Source: OpenAlex

  31. Metastatik meme kanseri hastalarında, primer tümör ve metastazda hormon reseptör ve her-2 ekspresyon değişiklikleri

    Source: acibadem.com.tr profile page

  32. Soluble endothelial cell protein C receptor and thrombomodulin levels after renal transplantation

    Source: acibadem.com.tr profile page

  33. Bileteral total kalça protezi sonrası gelişen primer kemik lenfoması.

    Source: acibadem.com.tr profile page